J. Boukovinas

Paclitaxel Plus Carboplatin Versus Gemcitabine Plus Paclitaxel in Advanced Non–Small-Cell Lung Cancer: A Phase III Randomized Trial

P. Kosmidis, Nick Mylonakis, C. Nicolaides et al. · Journal of Clinical Oncology · 2002 · 255 citations

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer

G. Stathopoulos, K. Syrigos, Gerasimos Aravantinos et al. · British Journal of Cancer · 2006 · 196 citations · Full text

Urology, Pancreatic Cancer, Gemcitabine Monotherapy +15

A Multicenter Phase II Study of the Combination of Irinotecan and Gemcitabine in Previously Treated Patients with Small-Cell Lung Cancer

Sofia Agelaki, K. Syrigos, Charalambos Christophylakis et al. · Oncology · 2004 · 16 citations

Sequential Versus Alternating Administration of Cisplatin/Etoposide and Topotecan as First-Line Treatment in Extensive-Stage Small-Cell Lung Cancer: Preliminary Results of a Phase III Trial of the Hellenic Oncology Research Group

Michail Ignatiadis, Dimitris Mavroudis, M. Veslemes et al. · Clinical Lung Cancer · 2005 · 14 citations

Medicine, Phase Iii Trial, Pathology +7

Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)

P. Kosmidis, George Fountzilas, Anastasia G Eleftheraki et al. · Annals of Oncology · 2010 · 14 citations